Sartorius Aktiengesellschaft (ETR:SRT)

Market Cap	14.43B
Revenue (ttm)	3.44B
Net Income (ttm)	95.60M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	150.99
Forward PE	n/a
Dividend	0.73 (0.39%)
Ex-Dividend Date	Mar 28, 2025

Volume	4,092
Average Volume	5,330
Open	185.80
Previous Close	187.80
Day's Range	181.80 - 189.40
52-Week Range	131.40 - 235.00
Beta	1.33
RSI	61.70
Earnings Date	Apr 16, 2025

About ETR:SRT

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cy...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1870
• Employees: 13,528
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: SRT

Financial Performance

In 2024, ETR:SRT's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.